Partnering to achieve a
common goal.

We’re all in this together

DxTerity® and clinical researchers share a common goal: to advance the understanding, treatment and management of immune-mediated disease. To that end, DxTerity is committed to providing researchers with integrated patient-centric services to drive deep discovery and rapid product commercialization.

Comprehensive Suite of Services

DxTerity’s diagnostic development process provides a full suite of services to advance the next generation of low-cost, high-volume molecular diagnostics through the commercialization process.

  • Direct-to-Patient Clinical Research

  • Precision Genomic Testing

  • IVD Product Co-development

Direct patient recruitment and from-home sample collection for large studies

Low-cost genomic solutions for molecular diagnostic discovery and clinical development

Co-development services for IVD products under US FDA Design Control and CE-IVD requirements

Novel Technology for Immune-Mediated Diseases

DxTerity’s proprietary technology stabilizes RNA at ambient temperature while eliminating complex sample preparation requirements through direct-from-sample processing. This unique technology supports genomic research and monitoring in immune-mediated disease applications both when the immune system creates an over-reaction as well as an under-reaction to internal and external factors.


Thank you for visiting

To view the site, please update your browser

This site works on all modern browsers with legacy support back through Internet Explorer 9. Please update by going to the link below.